Log in
Enquire now
‌

US Patent 10501438 Aryl-substituted dihydroquinolinones, their preparation and their use as pharmaceuticals

Patent 10501438 was granted and assigned to NeoMed on December, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
NeoMed
NeoMed
0
Current Assignee
NeoMed
NeoMed
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
105014380
Patent Inventor Names
Shawn Johnstone0
Guillaume Jacquemot0
Jeffrey S. Albert0
Malken Bayrakdarian0
Andrew Griffin0
Date of Patent
December 10, 2019
0
Patent Application Number
157518000
Date Filed
August 11, 2016
0
Patent Primary Examiner
‌
Kahsay Habte
0
Patent abstract

This application relates to aryl-substituted dihydroquinolinones of formula (I), compositions comprising them and their uses in the treatment of diseases and conditions in which inhibition of a bromodomain is indicated. For example, the application relates to aryl-substituted dihydroquinolinones and to their use as bromodomain inhibitors. The present application is also related to the treatment or prevention of proliferative disorders, auto-immune disorders, inflammatory disorders, dermal disorders, and neoplasms, including tumors and/or cancers.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10501438 Aryl-substituted dihydroquinolinones, their preparation and their use as pharmaceuticals

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.